Anilkumar Gopalakrishnapillai

2.0k total citations
64 papers, 1.4k citations indexed

About

Anilkumar Gopalakrishnapillai is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Anilkumar Gopalakrishnapillai has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Hematology and 16 papers in Oncology. Recurrent topics in Anilkumar Gopalakrishnapillai's work include Acute Myeloid Leukemia Research (23 papers), CAR-T cell therapy research (11 papers) and Metabolism, Diabetes, and Cancer (8 papers). Anilkumar Gopalakrishnapillai is often cited by papers focused on Acute Myeloid Leukemia Research (23 papers), CAR-T cell therapy research (11 papers) and Metabolism, Diabetes, and Cancer (8 papers). Anilkumar Gopalakrishnapillai collaborates with scholars based in United States, India and Germany. Anilkumar Gopalakrishnapillai's co-authors include Ayyappan K. Rajasekaran, Sonali P. Barwe, Jason J. Christiansen, Sigrid A. Rajasekaran, E. Anders Kolb, Neil H. Bander, Asoke Banerji, Ninu Poulose, James U. Bowie and Warren D.W. Heston and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Anilkumar Gopalakrishnapillai

63 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anilkumar Gopalakrishnapillai United States 18 747 294 256 233 184 64 1.4k
Allard Kaptein Netherlands 20 1.1k 1.5× 117 0.4× 478 1.9× 82 0.4× 225 1.2× 39 2.3k
Ranjini K. Sundaram United States 20 557 0.7× 111 0.4× 369 1.4× 38 0.2× 149 0.8× 45 1.4k
Lan Wang China 25 905 1.2× 148 0.5× 274 1.1× 222 1.0× 118 0.6× 74 1.8k
Claire Racaud‐Sultan France 22 951 1.3× 137 0.5× 320 1.3× 51 0.2× 318 1.7× 40 1.8k
Hudie Wei China 14 835 1.1× 142 0.5× 550 2.1× 155 0.7× 69 0.4× 31 1.5k
Ellis W.T. Wong Italy 6 1.6k 2.1× 218 0.7× 727 2.8× 45 0.2× 115 0.6× 10 2.3k
Paula Sotomayor United States 22 658 0.9× 307 1.0× 298 1.2× 47 0.2× 23 0.1× 32 1.3k
Jiyeon Ahn South Korea 22 830 1.1× 170 0.6× 197 0.8× 89 0.4× 40 0.2× 56 1.4k
Juan Guevara United States 14 656 0.9× 90 0.3× 140 0.5× 70 0.3× 78 0.4× 30 1.7k

Countries citing papers authored by Anilkumar Gopalakrishnapillai

Since Specialization
Citations

This map shows the geographic impact of Anilkumar Gopalakrishnapillai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anilkumar Gopalakrishnapillai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anilkumar Gopalakrishnapillai more than expected).

Fields of papers citing papers by Anilkumar Gopalakrishnapillai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anilkumar Gopalakrishnapillai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anilkumar Gopalakrishnapillai. The network helps show where Anilkumar Gopalakrishnapillai may publish in the future.

Co-authorship network of co-authors of Anilkumar Gopalakrishnapillai

This figure shows the co-authorship network connecting the top 25 collaborators of Anilkumar Gopalakrishnapillai. A scholar is included among the top collaborators of Anilkumar Gopalakrishnapillai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anilkumar Gopalakrishnapillai. Anilkumar Gopalakrishnapillai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Hua, Hong-Fen Guo, Maegan L. Capitano, et al.. (2025). Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway. Nature Communications. 16(1). 6369–6369. 1 indexed citations
2.
Gopalakrishnapillai, Anilkumar, et al.. (2023). Tetraspanins set the stage for bone marrow microenvironment–induced chemoprotection in hematologic malignancies. Blood Advances. 7(16). 4403–4413. 3 indexed citations
3.
Gopalakrishnapillai, Anilkumar, et al.. (2023). Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine–Panobinostat Combination. Cancers. 15(12). 3112–3112. 1 indexed citations
4.
Barwe, Sonali P., Fei Huang, E. Anders Kolb, & Anilkumar Gopalakrishnapillai. (2022). Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts. Journal of Clinical Medicine. 11(7). 1923–1923. 14 indexed citations
6.
Barwe, Sonali P., Anne Kisielewski, Ezio Bonvini, et al.. (2022). Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia. Journal of Clinical Medicine. 11(5). 1333–1333. 4 indexed citations
7.
Kolb, E. Anders, et al.. (2022). Mesothelin: An Immunotherapeutic Target beyond Solid Tumors. Cancers. 14(6). 1550–1550. 54 indexed citations
8.
Barwe, Sonali P., Fei Huang, E. Anders Kolb, & Anilkumar Gopalakrishnapillai. (2021). Imetelstat Significantly Reduces Leukemia Stem Cells in Patient-Derived Xenograft Models of Pediatric AML. Blood. 138(Supplement 1). 3352–3352. 1 indexed citations
9.
10.
Gopalakrishnapillai, Anilkumar, Colin Correnti, Ashok D. Bandaranayake, et al.. (2021). Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies. Cancers. 13(23). 5964–5964. 6 indexed citations
13.
Gopalakrishnapillai, Anilkumar, et al.. (2020). CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia. Blood Advances. 4(18). 4393–4405. 17 indexed citations
14.
Barwe, Sonali P., et al.. (2020). Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology. Molecular Therapy — Methods & Clinical Development. 19. 201–209. 13 indexed citations
15.
Gopalakrishnapillai, Anilkumar, et al.. (2017). Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia. Leukemia Research. 56. 36–43. 8 indexed citations
17.
Poulose, Ninu, et al.. (2011). Ellagic Acid Stimulates Glucose Transport in Adipocytes and Muscles through AMPK Mediated Pathway. Journal of Diabetes & Metabolism. 2(5). 25 indexed citations
18.
Rajasekaran, Ayyappan K., Anilkumar Gopalakrishnapillai, & Jason J. Christiansen. (2005). Is prostate-specific membrane antigen a multifunctional protein?. American Journal of Physiology-Cell Physiology. 288(5). C975–C981. 168 indexed citations
19.
Barwe, Sonali P., Anilkumar Gopalakrishnapillai, Sun Young Moon, et al.. (2004). Novel Role for Na,K-ATPase in Phosphatidylinositol 3-Kinase Signaling and Suppression of Cell Motility. Molecular Biology of the Cell. 16(3). 1082–1094. 134 indexed citations
20.
Gopalakrishnapillai, Anilkumar, Sigrid A. Rajasekaran, Song Wang, et al.. (2003). Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity.. PubMed. 63(10). 2645–8. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026